REVIEW
|
doi:10.20944/preprints202306.0380.v1
Subject:
Public Health And Healthcare,
Health Policy And Services
Keywords:
Biosimilars 1; Arab states 1; regulatory guideline 3; harmonization 4; centralized approval 5; EMA 6; FDA 7; Global Medicine Authority (GMA) 8.
Online: 6 June 2023 (08:49:00 CEST)